221 related articles for article (PubMed ID: 35024776)
1. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
[TBL] [Abstract][Full Text] [Related]
2. Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Raghavan A; Srinivasan M; O'Brien KS; Zegans M; McLeod SD; Acharya NR; Keenan JD; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2016 Jun; 134(6):693-6. PubMed ID: 27054515
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Lalitha P; Sun CQ; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Cevallos V; McLeod SD; Acharya NR; Lietman TM;
Am J Ophthalmol; 2014 Feb; 157(2):318-26. PubMed ID: 24439440
[TBL] [Abstract][Full Text] [Related]
4. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
[TBL] [Abstract][Full Text] [Related]
5. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
6. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
[TBL] [Abstract][Full Text] [Related]
8. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
Lalitha P; Prajna NV; Oldenburg CE; Srinivasan M; Krishnan T; Mascarenhas J; Vaitilingam CM; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM
Cornea; 2012 Jun; 31(6):662-7. PubMed ID: 22333662
[TBL] [Abstract][Full Text] [Related]
9. Medical interventions for fungal keratitis.
FlorCruz NV; Evans JR
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD004241. PubMed ID: 25855311
[TBL] [Abstract][Full Text] [Related]
10. Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
Gupta MK; Chandra A; Prakash P; Tilak R
J Mycol Med; 2018 Mar; 28(1):201-205. PubMed ID: 29398639
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
[TBL] [Abstract][Full Text] [Related]
12. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Das M; Ray KJ; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Sep; 135(9):987-991. PubMed ID: 28817744
[TBL] [Abstract][Full Text] [Related]
15. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
[TBL] [Abstract][Full Text] [Related]
16. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Sun CQ; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Acharya NR; Lietman TM
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4167-73. PubMed ID: 23702779
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
Pickel J; Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Porco TC; Redd T; Lietman TM; Rose-Nussbaumer J
Am J Ophthalmol; 2020 Jul; 215():1-7. PubMed ID: 32171765
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
Martinez PS; Whitley RD; Plummer CE; Richardson RL; Hamor RE; Wellehan JFX
Vet Ophthalmol; 2022 Sep; 25(5):376-384. PubMed ID: 35684950
[TBL] [Abstract][Full Text] [Related]
20. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of
Manikandan P; Abdel-Hadi A; Randhir Babu Singh Y; Revathi R; Anita R; Banawas S; Bin Dukhyil AA; Alshehri B; Shobana CS; Panneer Selvam K; Narendran V
Biomed Res Int; 2019; 2019():6395840. PubMed ID: 30800674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]